| Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy | TA1040 | | |
| Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over | TA1033 | | |
| Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment | HTE12 | | |
| Intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary intervention | IPG802 | | |
| Ovarian cancer | QS18 | | |
| Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatment | TA1036 | | |
| Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer | TA1037 | | |
| Digital technologies to support self-management of COPD: early value assessment | HTE19 | | |
| Tobacco: preventing uptake, promoting quitting and treating dependence | NG209 | | |
| Epilepsies in children, young people and adults | NG217 | | |
| Gambling-related harms: identification, assessment and management | NG248 | | |
| Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease | TA1035 | | |
| Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours | TA1034 | | |
| Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal) | TA1032 | | |
| Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over | TA1031 | | |
| Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years | NG247 | | |
| Bimekizumab for treating moderate to severe hidradenitis suppurativa (terminated appraisal) | TA1028 | | |
| Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal) | TA1029 | | |
| Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer | TA1030 | | |
| Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban | TA697 | | |
| Digitally enabled therapies for adults with depression: early value assessment | HTE8 | | |
| Artificial intelligence technologies to help detect fractures on X-rays in urgent care: early value assessment | HTE20 | | |
| Overweight and obesity management | NG246 | | |
| Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adults | IPG799 | | |
| Tebentafusp for treating advanced uveal melanoma | TA1027 | | |